Thrombosis Journal

Article	Citations
An in situ inferior vena cava ligation-stenosis model to study thrombin generation rates with flow	56
Superior sagittal sinus thrombosis in the course of mixed phenotype acute leukaemia treated with acute lymphoblastic leukaemia-like therapy—a case report	49
Risk of recurrent venous thromboembolism and major bleeding according to risk factor profiles in Asian patients: a subgroup analysis EINSTEIN-Extension and EINSTEIN-CHOICE	42
Monitoring heparin therapy: stability of two different anti-Xa assays using blood samples collected in citrate-containing and CTAD tubes	31
Effect of different balloon pressure band compression regimens on thrombolysis and lower limb venous blood flow velocity in patients undergoing anterograde thrombolysis via the superficial dorsalis pe	30
Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy	29
Association between red cell distribution width-to-lymphocyte ratio and 30-day mortality in patients with ischemic stroke: a retrospective cohort study	25
Factors associated with thrombosis among solid organ cancer patients in Kuala Lumpur, Malaysia	25
Association of elevated circulating monocyte-platelet aggregates with hypercoagulability in patients with nephrotic syndrome	24
Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis	22
Balancing the risks: continuous vs. interrupted anticoagulation during TAVI – what does the evidence say?	21
A snake venom-analog peptide that inhibits SARS-CoV-2 and papain-like protease displays antithrombotic activity in mice arterial thrombosis model, without interfering with bleeding time	20
Low-density lipoprotein cholesterol-to-lymphocyte count ratio (LLR) is a promising novel predictor of postoperative new-onset deep vein thrombosis following open wedge high tibial osteotomy: a propens	19
The use of infrared thermography for non-invasive detection of bleeding and musculoskeletal abnormalities in patients with hemophilia: an observational study	19
The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study	19
Comparison between canine and porcine models of chronic deep venous thrombosis	18
Prognostic significance of stress hyperglycemia ratio in patients with type 2 diabetes mellitus and acute coronary syndromes	18
The usefulness of tranexamic acid for bleeding symptoms of chronic consumptive coagulopathy complicated by aortic disease: a single-institute, retrospective study of 14 patients	18
Reduced mortality associated with pulmonary embolism response team consultation for intermediate and high-risk pulmonary embolism: a retrospective cohort study	17
Safety and efficacy of direct oral anticoagulation in patients with and without radiofrequency ablation of non-valvular atrial fibrillation: a multicenter retrospective cohort study	17
Efficacy and safety of direct oral anticoagulants in pediatric congenital and acquired heart disease: a systematic review and meta-analysis of randomized controlled trials	17
Efficacy, safety, and influencing factors of AngioJet mechanical thrombectomy versus catheter-directed thrombolysis in the treatment of acute lower limb deep vein thrombosis	16
Sex-specific associations between systolic, diastolic and pulse pressure and hemostatic parameters in the population-based KORA-Fit study: a cross-sectional study	16
Efficacy and safety of oral anticoagulants in elderly patients with stable coronary artery disease and atrial fibrillation	16
Implementation of early prophylaxis for deep-vein thrombosis in intracerebral hemorrhage patients: an observational study from the Chinese Stroke Center Alliance	15

Recurrent arterial and venous thrombosis in a 39-year-old male with Factor V Leiden syndrome and aneurysmal disease: a case report and review of the literature	15
Effect of direct oral anticoagulant therapy on pulmonary artery clot dissolution in intermediate high-risk pulmonary thromboembolism	14
Structure, signal transduction, activation, and inhibition of integrin αIIbβ3	14
Lipoxin A4 analogue, BML-111, reduces platelet activation and protects from thrombosis	14
Postoperative intermittent pneumatic compression for preventing venous thromboembolism in Chinese lung cancer patients: a randomized clinical trial	13
Factors associated with venous thromboembolic disease due to failed thromboprophylaxis	13
High thrombotic burden in severe Chinese wAIHA patients: a single-center retrospective study	13
The interaction of fibrinolysis and the complement system in patients with acute pulmonary embolism, treated with ultrasound-assisted catheter-directed thrombolysis	13
Net reclassification index in comparison of prognostic value of disseminated intravascular coagulation diagnostic criteria by Japanese Society on Thrombosis and Hemostasis and International Society on	12
A single-center study of reference intervals for TAT, PIC, TM and t-PAIC in healthy older Chinese adults	12
SERPINC1 c.1247dupC: a novel SERPINC1 gene mutation associated with familial thrombosis results in a secretion defect and quantitative antithrombin deficiency	12
Exploring the genetic basis between inflammatory bowel disease and venous thromboembolism	12
Treatment of pacemaker-induced superior vena cava syndrome by direct oral anticoagulant	12
Identification of key risk factors for venous thromboembolism in urological inpatients based on the Caprini scale and interpretable machine learning methods	12
Spontaneous rectus sheath hematoma associated with apixaban in an elderly gentleman with chronic obstructive airway disease – a case report	12
The risk factors of liver cirrhosis complicated with portal vein thrombosis and the efficacy and safety of anticoagulant therapy: a meta analysis	12
Incidence, outcomes, and risk factors of Heparin-induced thrombocytopenia in patients undergoing primary and revision knee arthroplasty	12
A post-marketing surveillance study on the safety and effectiveness of recombinant antithrombin gamma in patients with congenital antithrombin deficiency in Japan	12
Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treated with Rivaroxaban	11
Antithrombotic therapy at discharge and prognosis in patients with chronic coronary syndrome and atrial fibrillation who underwent PCI: a real-world study	11
Correlation between a 2-week change in platelet count and clinical outcomes after the initiation of ravulizumab treatment in adult patients with atypical hemolytic uremic syndrome: post-hoc analysis o	11
Clopidogrel vs. ticagrelor in ST-elevation myocardial infarction complicated by cardiogenic shock undergoing primary PCI	11
Cancer-Associated Thrombosis (CAT); mechanisms and treatment options	11
Gender-specific relationships between hyperuricemia and idiopathic deep venous thrombosis in the Chinese population: a case‒control study	11
A case report of spontaneous pectoral hematoma in a male with background antiplatelet therapy after severe COVID-19 infection	11
Anticoagulation control, outcomes, and associated factors in long-term-care patients receiving warfarin in Africa: a systematic review	11
Elevated tricuspid peak systolic gradient with enlarged right ventricle present during acute episode of pulmonary embolism predict subsequent chronic thromboembolic pulmonary hypertension	11
Aspirin and clopidogrel resistance; a neglected gap in stroke and cardiovascular practice in Iran: a systematic review and meta-analysis	11
Risk factor analysis and development of nomogram prediction model for central venous catheter-related thrombosis in burn patients: a retrospective observational study	10
Research advances on platelet glycoprotein VI in ischemic stroke	10
Bleeding and thrombotic events in patients with heparin-induced thrombocytopenia: a two-decade single-center experience in Thailand	10
An integrative analysis of genetic factors reveals dysregulation of cytokines, immune signaling, and T cell activity as the underlying immune mechanisms in autoimmune immune thrombocytopenia	10
Clinical features and risk factors for poor prognosis in malignant tumor patients with pulmonary embolism: a case control study	10
Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis	10
Enhanced in vivo and ex vivo thrombin generation after lower-leg trauma, but not after knee arthroscopy	10
Education and clinical pharmacist-led management strategies for the risk and prophylaxis of venous thromboembolism in general surgery	10
Association of inherited thrombophilia mutations and their combinations among palestinian women with unexplained recurrent miscarriage	10
The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation	10
Clinical trial assessing the safety of edoxaban with concomitant chemotherapy in patients with gynecological cancer-associated thrombosis (EGCAT study)	10
Process and outcome evaluation of a regional pulmonary embolism response team	10
Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism	9
Causal inference of sex hormone-binding globulin on venous thromboembolism: evidence from Mendelian randomisation	9
Assessing outcomes after thrombectomy with or without iliac vein stenting for young provoked DVT patients with iliac vein stenosis	9
Lupus anticoagulant associated with low grade B-cell lymphoma and IgM paraproteinaemia with lupus cofactor phenomenon on DRVVT and SCT assays - a possible novel association	9
Correction: Outcomes of deep venous thrombosis management and associated factors among patients in tertiary hospitals in Addis Ababa, Ethiopia: a multicenter retrospective cohort study	9
Causes of death after first time venous thromboembolism	9
A case of acquired thrombotic thrombocytopenic purpura induced by acute severe hepatitis E: successfully treated by plasma exchange and rituximab	9
Practical approach to thrombocytopenia in patients with sepsis: a narrative review	9
Heparin-free after 3000 IU heparin loaded in veno-venous ECMO supported acute respiratory failure patients with hemorrhage risk: a novel anti-coagulation strategy	9
Efficacy and safety of anticoagulant therapy in patients with sepsis: a meta-analysis of randomized controlled trials	9

Enoxaparin dosing for venous thromboembolism prophylaxis in hospitalized underweight adult patients: a retrospective cohort study	9
Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort study	9
Coagulation dysfunction events associated with echinocandins: a real-world study from FDA adverse event reporting system (FAERS) database	8
Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system	8
Escalating doses of intravenous APAC demonstrate antithrombotic effect in pigs	8
A nomogram for individualized prediction of calf muscular venous thrombosis in patients with acute ischemic stroke: a retrospective study	8
Deep vein thrombosis in Ethiopia: a systematic review and meta-analysis, 2025	8
Catheter-directed therapy for pulmonary embolism in pediatrics: a systematic review and meta-analysis	8
Prevalence of venous thromboembolism and evaluation of a modified caprini risk assessment model: a single-centre, prospective cohort study involving patients undergoing lung resections for bronchiecta	8
A study of recurrent life-threatening thrombosis accompanied with the duplication of the factor IX gene	8
Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE	8
A comparative study on early prediction of venous thromboembolism in patients with traumatic brain injury by machine learning model	8
Venous thromboembolic disease in admitted blunt trauma patients: what matters?	7
Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia	7
The clinical application of venous ultrasound in diagnosis and follow-up of lower extremity deep vein thrombosis (DVT): a case-based discussion	7
Incidence and risk factors of venous thrombotic events in patients with interstitial lung disease during hospitalization	7
Long noncoding RNA TUG1 induces angiogenesis of endothelial progenitor cells and dissolution of deep vein thrombosis	7
Acquired factor V inhibitor masked by triple antithrombotic therapy presenting as severe gastrointestinal bleeding: a case report	7
Acquired circulating heparin-like anticoagulants associated with multiple myeloma: three cases reports and literature review	7
A primary pulmonary artery sarcoma masquerading pulmonary embolism: a case report and literature review	7
Adrenal hemorrhage following direct oral anticoagulant (DOAC) therapy: two case reports and literature review	7
Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais	7
Coagulation biomarkers and coronavirus disease 2019 phenotyping: a prospective cohort study	7
Perioperative inflammatory and coagulation biomarkers for predicting venous thromboembolism after lower limb fracture surgery	7
The effect of neutrophil extracellular traps in venous thrombosis	7
Insulin resistance, metabolic syndrome and micro-RNA-122 serum level in patients with cerebral venous sinus thrombosis: a case-control study	7
“Y appearance” infarction: caused by essential thrombocythemia	6
Causal relationship between varicose veins and mean corpuscular hemoglobin concentration based on Mendelian randomization study	6
Anticoagulant management in an antithrombin-deficient pregnant woman with a history of venous thromboembolism: a case report	6
Lemierre’s syndrome complicating deep neck abscess: a case report	6
Pregnancy and thrombosis risk for women without a history of thrombotic events: a retrospective study of the real risks	6
LMWHs dosage and outcomes in acute pulmonary embolism with renal insufficiency, an analysis from a large real-world study	6
A retrospective multicenter cohort study of the association between anti-Factor Xa values and death, thromboembolism, and bleeding in patients with critical COVID-19	6
miR-1915-3p regulates megakaryocytic and erythroid differentiation by targeting SOCS4	6
Predictors of pulmonary embolism in hospitalized patients with COVID-19	6
Genetic and clinical characterization of two families with severe venous thromboembolism due to nonsense mutations in the SERPINC1 gene	6
Early identification of lung cancer patients with venous thromboembolism: development and validation of a risk prediction model	6
External validation and update of the International Medical Prevention Registry on Venous Thromboembolism bleeding risk score for predicting bleeding in acutely ill hospitalized medical patients: a re	6
Synergistic effects of rivaroxaban and hypothermia or acidosis on coagulation initiation measured with ROTEM®: a prospective observational study	6
Causal association between circulating blood cell traits and pulmonary embolism: a mendelian randomization study	6
Monitoring the efficiency of reversal on anti-Xa direct oral anticoagulants using point-of-care viscoelastic testing	6
The effect of Mycobacterium tuberculosis treatment on thrombelastography-assessed haemostasis: a prospective cohort study	6
Chronic anti-coagulation therapy reduced mortality in patients with high cardiovascular risk early in COVID-19 pandemic	6
Risk factors for deep venous thrombosis following total hip arthroplasty: a meta-analysis	5
Association between cancer history and second-generation drug-eluting stent thrombosis: insights from the REAL-ST registry	5
The correlation of lupus anticoagulant and anticardiolipin antibodies with hematological parameters and clinical findings in sickle cell disease at steady state phase	5
Reply to correspondence: Cancer incidence and mortality after a first-ever venous thrombosis in northern Sweden	5
The prevalence and risk factors of pulmonary embolism in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis	5
Impact of baseline renal function on the efficacy and safety of different Anticoagulants in Atrial Fibrillation Patients – A cohort study	5
Thromboembolic events associated with angiogenesis inhibitors: a real-world study of data from the food and drug administration adverse event reporting system (FAERS) database	5
Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study	5
Testing P2Y12 platelet inhibitors generics beyond bioequivalence: a parallel single-blinded randomized trial	5
Management of edoxaban therapy and clinical outcomes in patients undergoing major or nonmajor surgery: a subanalysis of the EMIT-AF/VTE study	5
Risk factors for thrombolysis-related intracranial hemorrhage: a systematic review and meta-analysis	5
Modified thromboelastometric tests provide improved sensitivity and specificity to direct oral anticoagulants compared to standard thromboelastometric tests in-vitro	5
Right heart thrombus in transit and peripherally inserted central catheters	5
Fibrinogen-to-albumin ratio and risk of thrombotic diseases incidence	5
A nomogram model for predicting preoperative DVT in elderly anemic patients undergoing total hip arthroplasty: a retrospective cohort study	5
Single-leaflet reconstruction surgery for severe chronic lower limb venous insufficiency caused by post-thrombotic syndrome: a case report and literature review	5
Parapneumonic effusion is a risk factor for VTE in hospitalized patients with community-acquired pneumonia: a retrospective cohort study	5
Robust preimplantation genetic testing of the common F8 Inv22 pathogenic variant of severe hemophilia A using a highly polymorphic multi-marker panel encompassing the paracentric inversion	5
Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma	5
Clinical characteristics of COVID-19 associated vasculopathic diseases	5
Popliteal vein aneurysm presenting in a patient with cerebral infarction and patent foramen ovale: a rare case with complex thrombotic events	5
A 11-year-old boy with Blastocystis hominis infection, presents as immune thrombocytopenia	5
Time series differences in coagulopathy in mechanically ventilated COVID-19 and bacterial pneumonia patients: a nationwide observational study in Japan	5
Anticoagulation strategy and safety in critically ill COVID-19 patients: a French retrospective multicentre study	5
Use of thromboelastography before the administration of hemostatic agents to safely taper recombinant activated factor VII in acquired hemophilia A: a report of three cases	5
Management of patients with protein s deficiency: focus on clinical course and direct oral anticoagulants	5
Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how	5
Establishment and validation of a predictive model for lower extremity deep vein thrombosis in patients with traumatic pelvic fractures	5
National trends in venous thromboembolism-related mortality among pancreatic cancer patients in the United States, 1999–2020	5
Systematic review and meta-analysis of association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss: an update	4
Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study	4
Laboratory and clinical haemostatic aberrations in primary dermatologic disease: A review	4
Under the dual effect of inflammation and pulmonary fibrosis, CTD-ILD patients possess a greater susceptibility to VTE	4
Anlotinib dramatically improved pulmonary hypertension and hypoxia caused by Pulmonary Tumor Thrombotic Microangiopathy (PTTM) associated with gastric carcinoma: a case report	4
A simple formula for predicting the warfarin dose in atrial fibrillation: development, external validation, and model comparison	4
Multiple venous thromboembolisms in a pregnant patient carrying a novel mutation in SERPINC1 (p.M313T) that causes a transient antithrombin deficiency: a case report	4
Pulmonary origin and risk assessment of cancer-associated thrombosis	4

Modern thromboprophylaxis protocol based on guidelines applied in a respiratory intensive care unit: a single-center prospective cohort study	4
Genetically predicted the causal association between serum mineral elements with immune thrombocytopenia and Henoch-Schonlein purpura: a bidirectional two-sample Mendelian randomization analysis	4
Outcomes of deep venous thrombosis management and associated factors among patients in tertiary hospitals in Addis Ababa, Ethiopia: a multicenter retrospective cohort study	4
Evaluation of Apixaban standard dosing in underweight patients with non-valvular atrial fibrillation: a retrospective cohort study	4
Enhanced platelets aggregation and coagulation of methicillin-resistant Staphylococcus aureus compared to methicillin-sensitive Staphylococcus aureus	4
Long-term efficacy and safety of anticoagulant for cavernous transformation of the portal vein cirrhotic patient with extrahepatic portal vein obstruction	4
Cortical vein involvement and its influence in a cohort of adolescents with cerebral venous thrombosis	4
Asundexian: a systematic review of safety, efficacy, and pharmacological insights in thrombosis	4
Correction: Prognostic value of plasma high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study	4
Direct oral anticoagulants versus warfarin for venous thromboembolism prophylaxis in nephrotic syndrome patients: a retrospective study	4
Association of initial national early warning score with clinical deterioration in pulmonary embolism	4
Patient self-management of warfarin therapy – a long-term follow up study	4
Extracellular PDI in thrombosis and vascular injury	4
Letter to editor: Impact of extracorporeal membrane oxygenation treatments on acquired von willebrand syndrome in patients with out of-hospital cardiac arrest: a retrospective observational study	4
Tranexamic acid for haemostasis and beyond: does dose matter?	4
Prognosis of incidental pulmonary embolism vs. symptomatic pulmonary embolism in cancer patients: a single-center retrospective cohort study in China	4
Immune thrombotic thrombocytopenic purpura and diabetic ketoacidosis: a case report and literature review	4
Neutrophil levels upon admission for the assessment of acute pulmonary embolism with intermediate- and high-risk: an indicator of thrombosis and inflammation	4
Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism	4
The potential impact of Covid-19 on the capacity of routine laboratory tests to detect heparin-induced thrombocytopenia	4
Characterization of anticoagulated patients in a Latin American country: indications, treatment patterns, and complications	4
Anticoagulant effects of edoxaban in cancer and noncancer patients with venous thromboembolism	3
The efficacy of tranexamic acid treatment with different time and doses for traumatic brain injury: a systematic review and meta-analysis	3
Haemostasis patterns in patients with acute-on-chronic liver failure and acute decompensation of cirrhosis including thromboelastometric tests with and without the addition of Protac: a pilot study	3
Rapid renal salvage in acute renal vein thrombosis secondary to membranous nephropathy using large-bore mechanical thrombectomy	3
A prediction model for left ventricular thrombus persistence/recurrence: based on a prospective study and a retrospective study	3
Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study	3
Renal damage and old age: risk factors for thrombosis in patients with ANCA-associated vasculitis	3
Progress in the clinical effects and adverse reactions of ticagrelor	3
External validation of four venous thromboembolism risk assessment models after colorectal cancer surgery: a retrospective study	3
Extended use of dual antiplatelet therapy among older adults with acute coronary syndromes and associated variables: a cohort study	3
Heparin-induced thrombocytopenia in extracorporeal membrane oxygenation-supported patients: a systematic review and meta-analysis	3
Cerebral venous sinus thrombosis associated with SRA-negative heparin-induced thrombocytopenia: case report	3
Antibiotic use in acute mesenteric ischemia: a review of the evidence and call to action	3
Clinical characteristics of venous thromboembolism onset from severe high altitude pulmonary edema in plateau regions	3
Real-world practices of low-molecular-weight heparin for venous thromboembolism prophylaxis in patients hospitalized with COVID-19: a multicenter prospective study from China	3
Recurrence in isolated distal DVT after anticoagulation: a systematic review and meta-analysis of axial and muscular venous thrombosis	3
The association between ROS1 rearrangement and risk of thromboembolic events in patients with advanced non-small cell lung cancer: a multicenter study in China	3
Direct oral anticoagulants compared to low molecular weight heparin for the treatment of venous thromboembolism among individuals with gastrointestinal cancer: an updated meta-analysis	3
Relationship between serum uric acid levels and pulmonary embolism: an age-based stratified analysis	3
Recurrent venous thrombosis in an adolescent male with CBS mutation and persistent antiphospholipid antibody positivity: a case report	3
Two cases of venous thromboembolism in siblings after splenectomy due to a novel PROC gene mutation	3
Predictive value of serum homocysteine and potassium ion for short-term prognosis of patients with acute cerebral infarction following intravenous thrombolysis with recombinant tissue plasminogen acti	3
Identification of two point mutations associated with inherited antithrombin deficiency	3
Portal vein thrombosis as a clinical dilemma in Echis carinatus envenomation: a case report and review of the literature	3
Utilization of the Caprini risk assessment model(RAM) to predict venous thromboembolism after primary hip and knee arthroplasty: an analysis of the Healthcare Cost and Utilization Project(HCUP)	3
Type 3 von Willebrand disease in Ethiopia: a comprehensive literature review and report of the first three cases	3
High incidence of undiagnosed deep vein thrombosis among hospitalized people living with HIV: a cross-sectional study	3
Restenosis after excimer laser coronary atherectomy and drug-coated balloon dilation in Takayasu’s arteritis: a case report and review of the literature	3
Association of the p.Phe155del mutation in SERPINC1 with changed antithrombin function and increased risk of venous thromboembolism: clinical and functional observations	3
Von Willebrand disease (VWD) and pregnancy: a comprehensive overview	3
Sepsis induced coagulopathy (SIC): is it monolithic?	3
D-dimer to fibrinogen ratio as a marker for acute cerebral venous thrombosis	3
Lupus anticoagulant hypoprothrombinemia syndrome successfully treated with rituximab – case report	3
A mendelian randomization study on the association between 731 types of immune cells and 91 types of blood cells with venous thromboembolism	3
Simplified predictive scores for thrombosis and bleeding complications in newly diagnosed acute leukemia patients	3
Narsoplimab for severe transplant-associated thrombotic microangiopathy	3
Diagnostic accuracy of D-dimer for predicting postpartum venous thromboembolism: a systematic review and meta-analysis	3
From bilateral pulmonary embolism to the final diagnosis of Behçet’s disease: a rare case report	3
Inflammatory biomarkers may be associated with poor outcomes after mechanical thrombectomy	3
Acute lower limb ischemia caused by vaccine-induced immune thrombotic thrombocytopenia: focus on perioperative considerations for 2 cases	3
Relationships between coagulation factors and thrombin generation in a general population with arterial and venous disease background	3
Reduced half-life of recombinant ADAMTS13 in a patient with cTTP undergoing total hip arthroplasty	3
Efficacy and safety of anticoagulation dose reduction for venous thromboembolism prophylaxis in low body weight patients: a systematic review and meta-analysis	2
Characterization of spreading depolarizations in swine following superior sagittal sinus occlusion: a novel gyrencephalic model study	2
Impact of extracorporeal membrane oxygenation treatments on acquired von Willebrand syndrome in patients with out-of-hospital cardiac arrest: a retrospective observational study	2
Risk of thrombotic events in immune thrombocytopenia patients treated with thrombopoietic agents: a systematic review and meta-analysis	2
Trends and disparities in disseminated intravascular coagulation-related mortality among adults aged 25 and above in the U.S., 1999–2020: CDC WONDER insights	2
A novel role for protein disulfide isomerase ERp18 in venous thrombosis	2
Association between liver fibrosis and thrombotic or bleeding events in acute coronary syndrome patients	2
D-dimer and fibrinogen indicate ischemic risk in patients with atrial fibrillation after percutaneous coronary intervention	2
Long non-coding RNA crnde promotes deep vein thrombosis by sequestering miR-181a-5p away from thrombogenic Pcyox1l	2
Eno1 in sepsis-induced coagulopathy: a pleiotropic mechanism hypothesis involving immunomodulation and endothelial dysfunction	2
The relationships between disseminated intravascular coagulation and time series change of Von Willebrand factor in patients with out-of-hospital cardiac arrest: a retrospective observational study	2
Anticoagulation control for nonvalvular atrial fibrillation in a tertiary academic centre in Johannesburg	2
Endoplasmic reticulum protein 29 negatively regulates platelet functions and thrombosis in mice	2
4G/5G polymorphism and plasma levels of plasminogen activator inhibitor-1 in essential thrombocythemia patients with driver mutational status	2
Clinical outcomes in patients receiving edoxaban or phenprocoumon for prevention of stroke in atrial fibrillation: a German real-world cohort study	2
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications	2
Hyperlipidemia in immune thrombocytopenia: a retrospective study	2
Hospitalized patients with isolated distal deep vein thrombosis: anticoagulation therapy or not?	2
Infrared thermography for detecting compensatory load in people with haemophilia: a cross-sectional study	2
Antiphospholipid antibodies are associated with increased levels of selected oxidative stress biomarkers	2
Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis	2
Echogenicity of carotid plaques as a predictor of regression following lipid-lowering therapy	2
Cancer-associated venous thromboembolism: a comprehensive review	2
A retrospective study on the clinical outcomes of endovascular intervention treatment for inferior vena cava filter thrombosis	2
Deep vein thrombosis in severe community-acquired pneumonia patients undergoing thromboprophylaxis: Prevalence, risk factors, and outcome	2
Efficacy and safety of anticoagulant for treatment and prophylaxis of VTE patients with renal insufficiency: a systemic review and meta-analysis	2
Hyper-responsiveness to warfarin in a young patient with the VKORC1 -1639GA/CYP2C9*1*46 genotype: a case report	2
Role of ticagrelor in the peri-thrombolytic phase for patients with ST-segment elevation myocardial infarction: a comprehensive review	2
Heparin therapy in sepsis and sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis	2
The effectiveness of atorvastatin for the prevention of deep vein thrombosis in cancer patients undergoing chemotherapy	2
Spontaneous coronary artery dissection in a young patient with antiphospholipid syndrome	2
Factors influencing DVT formation in sepsis	2